<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html id="Html1" lang="en" xmlns="http://www.w3.org/1999/xhtml">
	<head id="Head1"><meta http-equiv="Content-type" content="text/html;charset=UTF-8" /><title>
	Palladium-activated prodrug therapy: a novel focal therapy for localised cancers of unmet need
</title>
<!--dc/egms metadata start-->
<meta name="DC.description" content="Grants on the web" />
<meta name="DC.title" content="Grants on the web"/>
<meta name="DC.creator" content="EPSRC author"/>
<meta name="DC.publisher" content="Engineering and Physical Sciences Research Council, Polaris House, North Star Avenue, Swindon, SN2 1ET"/>
<meta name="DC.language" content="en" />
<meta name="eGMS.subject.category" content="epsrc, research council, grant, grants, funds, funding, physical science, engineering, engineer, engineers, graduate, postgraduate, college, university, universities, education, academic, student, students, support, training, proposal, proposals, polaris house, swindon, uk, government, research, counsel, counsil, councils, science, sciences, scientist, scientists" />
<meta name="eGMS.subject.keyword" content="epsrc, research council, grant, grants, funds, funding, physical science, engineering, engineer, engineers, graduate, postgraduate, college, university, universities, education, academic, student, students, support, training, proposal, proposals, polaris house, swindon, uk, government, research, counsel, counsil, councils, science, sciences, scientist, scientists" />
<!--dc/egms metadata end-->
<link href="GOW2.css" type="text/css" rel="stylesheet" />
		<script type="text/javascript" src="gowweb.js"></script>
	</head>
	<body>
		<form name="Form1" method="post" action="NGBOViewGrant.aspx?GrantRef=EP%2fN021134%2f1" id="Form1">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" />

<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEWAwL+h6LODALQvN++DAKT/OCVAyJIwnGK2HI9Y9P+1JCoOvGsGXc/" />
			
<script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-12650009-3']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>
<div class="header"><a href="http://www.epsrc.ac.uk"><img src="http://gow.epsrc.ac.uk//images/epsrclogo.png" alt="EPSRC logo" style="margin-top: 10px;" /></a>
<div class="searchboxposition"><label for="GOWGPHeader1_txtSearch" id="GOWGPHeader1_lblSearch" class="HiddenLabel">Search this site</label>
<input name="GOWGPHeader1$txtSearch" type="text" value="GoW Search" id="GOWGPHeader1_txtSearch" class="SearchText" onclick="javascript:document.getElementById('GOWGPHeader1_txtSearch').select();document.getElementById('GOWGPHeader1_txtSearch').focus();" onkeypress="o=this.name;" />
<label for="GOWGPHeader1_btnSearch" id="GOWGPHeader1_Label1" class="HiddenLabel">Search this site</label>
<input type="submit" name="GOWGPHeader1$btnSearch" value="Go" onclick="javascript:WebForm_DoPostBackWithOptions(new WebForm_PostBackOptions(&quot;GOWGPHeader1$btnSearch&quot;, &quot;&quot;, true, &quot;&quot;, &quot;&quot;, false, false))" id="GOWGPHeader1_btnSearch" class="SearchButton" onkeypress="" /></div>
</div>
<ul id="topnav">
	<li><a id="aHome" class="menubox1off" href="http://www.epsrc.ac.uk">Home</a></li>
	<li><a id="aGoWHome" class="menubox1off" href="http://gow.epsrc.ac.uk/NGBODefault.aspx">GoW Home</a></li>
	<li><a id="aBack" class="menubox1off" href="javascript:history.go(-1)">Back</a></li>
	<li class="menuboxspacer">&nbsp;</li>
	
	<li><a class="menubox1off" href="http://gow.epsrc.ac.uk/NGBOListResearchAreas.aspx">Research Areas</a></li>
	<li><a class="menubox1off" href="http://gow.epsrc.ac.uk/NGBOListTopics.aspx">Topic</a></li>
	<li><a class="menubox1off" href="http://gow.epsrc.ac.uk/NGBOListSectors.aspx">Sector</a></li>
	<li><a class="menubox1off" href="http://gow.epsrc.ac.uk/NGBOListSchemes.aspx">Scheme</a></li>
	<li><a class="menubox1off" href="http://gow.epsrc.ac.uk/NGBOChooseRegion.aspx">Region</a></li>
	<li><a class="menubox1off" href="http://gow.epsrc.ac.uk/NGBOListThemes.aspx">Theme</a></li>
	<li><a class="menubox1off" href="http://gow.epsrc.ac.uk/NGBOListOrganisations.aspx">Organisation</a></li>
	<li><a class="menubox1off" href="http://gow.epsrc.ac.uk/NGBOListPartners.aspx">Partners</a></li>
</ul>
<div class="clearfloat"></div>
			<div id="pnlFound">
	
				<h1>Details of Grant&nbsp;</h1> 
				<p>
                    
                    
                </p>
				<table id="tblFound" cellspacing="0" cellpadding="0" width="100%" class="bordered" summary="grant details">
		<tr>
			<td class="DetailName" style="width:20%">EPSRC Reference:</td>
			<td class="DetailValueAlt" colspan="5"> 
							<span id="lblGrantReference" class="DetailValueAlt">EP/N021134/1</span></td>
		</tr>
		<tr>
			<td class="DetailName">Title:</td>
			<td colspan="5">
							<span id="lblTitle" class="DetailValue"><strong>Palladium-activated prodrug therapy: a novel focal therapy for localised cancers of unmet need</strong></span></td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">Principal Investigator:</td>
			<td colspan="5" class="borderedAlt">
							<a id="hlPrincipalInvestigator"><a href='NGBOViewPerson.aspx?PersonId=-243788'>Unciti-Broceta, Dr A</a></a></td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">Other Investigators:</td>
			<td class="bordered" colspan="5" style="padding-left: 3px">
                            
                                    <table width='100%' class="notbordered" cellspacing='0' cellpadding='0'> 
                                
                                  <tr>
                                    <td style="width:33%" class="DetailValue"> <a href='NGBOViewPerson.aspx?PersonId=-369681'>Patton, Dr E</a></td>
                                    <td style="width:33%" class="DetailValue"> <a href='NGBOViewPerson.aspx?PersonId=116696'>Leung, Professor HY</a></td>
                                    <td class="DetailValue"> <a href='NGBOViewPerson.aspx?PersonId=-456060'>Carragher, Dr N</a></td>
                                  </tr>
                                
                                  <tr>
                                    <td style="width:33%" class="DetailValueAlt"> <a href='NGBOViewPerson.aspx?PersonId=-529868'>Brennan, Dr P</a></td>
                                    <td style="width:33%" class="DetailValueAlt"> </td>
                                    <td class="DetailValueAlt"> </td>
                                  </tr>
                                
                                    </table>
                                
                           </td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">Researcher Co-Investigators:</td>
			<td colspan="5" class="borderedAlt" style="padding-left: 3px">
                            
						</td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">Project Partners:</td>
			<td colspan="5" class="bordered" style="padding-left: 3px">
                            
							</td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">Department:</td>
			<td class="DetailValueAlt" colspan="5">
							<span id="lblDepartment" class="DetailValueAlt">Edinburgh Cancer Research Centre</span></td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">Organisation:</td>
			<td class="DetailValue" colspan="5">
							<span id="lblOrganisation" class="DetailValue">University of Edinburgh</span></td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">Scheme:</td>
			<td colspan="5" class="DetailValueAlt">
							<span id="lblAwardType" class="DetailValueAlt">Standard Research</span></td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">Starts:</td>
			<td class="DetailValue">
							<span id="lblStarts" class="DetailValue">01 April 2016</span></td>
			<td class="DetailName" style="text-align:center;">Ends:</td>
			<td class="DetailValue">
							<span id="lblEnds" class="DetailValue">31 March 2021</span></td>
			<td class="DetailName" style="text-align:center;">Value (£):</td>
			<td class="DetailValue">
							<span id="lblValue" title="1,074,211.90" class="DetailValue">1,074,212</span>
							</td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%">EPSRC Research Topic Classifications:</td>
			<td colspan="5" class="borderedAlt" style="padding-left: 3px">
						     
                                    <table width="100%" class="bordered" cellspacing="0" cellpadding="0" summary="topic classifications"> 
                                
                                  <tr>
                                    <td style="width:50%" class="DetailValue"> Biological &amp; Medicinal Chem.</td>
                                    <td class="DetailValue"> Biomaterials</td>
                                  </tr>
                                
                                  <tr>
                                    <td style="width:50%" class="DetailValueAlt"> Catalysis &amp; Applied Catalysis</td>
                                    <td class="DetailValueAlt"> </td>
                                  </tr>
                                
                                    </table>
                                
						</td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%;">EPSRC Industrial Sector Classifications:</td>
			<td colspan="5" class="bordered" style="padding-left: 3px">
						     
                                  <table width="100%" class="bordered" cellspacing="0" cellpadding="0" summary="sector classifications"> 
                                
                                  <tr>
                                    <td style="width:50%;" class="DetailValueAlt"> Pharmaceuticals and Biotechnology</td>
                                    <td class="DetailValueAlt"> </td>
                                  </tr>
                                
                                    </table>
                                
						</td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%;"> Related Grants:</td>
			<td colspan="5" class="borderedAlt" style="padding-left: 3px">
                            
							
							
						</td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%;">Panel History:</td>
			<td colspan="5" class="bordered">
							<table class="bordered" cellspacing="0" cellpadding="1" rules="all" border="1" id="dgPanelHistory" width="100%">
				<tr class="DetailTitle">
					<td>Panel Date</td><td>Panel Name</td><td>Outcome</td>
				</tr><tr class="DetailValue">
					<td nowrap="nowrap">
                                                     <span id="dgPanelHistory_ctl02_Label1"><b>24 Nov 2015</b></span>
                                                </td><td title="Link to panel" align="left" valign="middle" width="70%">
																	<a id="dgPanelHistory_ctl02_lnkPanelName" href="NGBOViewPanel.aspx?PanelId=1-392UDW">Healthcare Technologies Challenge Awards Interviews Panel B</a>
																	
												</td><td valign="middle">
																	<span id="dgPanelHistory_ctl02_Label3"><b>Announced</b></span>
												</td>
				</tr>
			</table></td>
		</tr>
		<tr>
			<td colspan="6" class="DetailTitle" style="text-align:center;">
                            Summary on Grant Application Form</td>
		</tr>
		<tr>
			<td colspan="6" class="DetailValue" style="padding:5px;">
                        <span id="lblAbstract">Despite significant advances in the diagnosis and treatment of the earliest stages of cancer, the highest life-threatening risks and therapeutic challenges still remain in developing effective treatment of patients diagnosed with locally advanced or metastatic tumours. For most localised tumours the current treatment is surgical resection, often followed by adjuvant radiotherapy and/or chemotherapy. The potential benefit of such therapies in any stage of the cancer must be weighed against possible adverse effects that can severely impair a patient's quality of life. Unfortunately, even with adjuvant chemotherapy to treat some aggressive cancers like glioblastoma multiforme, the median survival is only improved around 2 months, while associated side effects are very severe. In addition, for localised prostate cancer, significant controversy remains on the optimal treatment options. Due to side effects (incontinence, impotence, bowel problems) of existing treatments (surgery or radiotherapy), current standard of care is active surveillance consisting of regular hospital tests (e.g. prostate biopsies and MRI scans), aimed at deferring intervention. Because of the lack of therapies providing a better balance between treatment efficacy and related toxicities, many of these cancers eventually evolve into a more aggressive form with increased risk of pre-mature death. Therefore, what is needed then are novel drug delivery strategies that can reduce the side effect profile of the treatment whilst maximising therapeutic efficacy. <br /><br />To provide a safer and more effective strategy to those localised cancers, we have devised a novel therapeutic approach that will allow concentrating drug activity only at the cancer area, thereby reducing the severe adverse effects associated with chemotherapy. The technology is based on a novel strategy pioneered at the Edinburgh Cancer Research Centre at the University of Edinburgh that enables full control over where chemotherapy takes action through the use of solid metal devices made of an element called palladium. This metal, which is completely safe to patients (it is already employed in dentistry), can be shaped into implantable devices and possesses exceptional chemical properties that facilitate the local release of anticancer drugs. By implantation inside localised tumour, orally-given drug precursors will only become "active" at the cancer site upon interaction with the palladium device. Given the reusability of this device, this treatment could be repeated as many times as necessary. The unique modulatory capabilities of this novel approach will not only reduce drug presence in healthy organs but will also facilitate personalized treatments to be implemented according to the progression and severity of the disease, thereby reducing side effects and maximizing the efficacy of the therapy. Due to its novelty, such healthcare technology will make a major impact in the Pharma sector and, in turn, in the NHS and people of the UK and worldwide by improving the quality of life and life expectancy of patients suffering from untreatable tumours.<br /><br /></span>
                        </td>
		</tr>
		<tr>
			<td colspan="6" class="DetailTitle" style="text-align:center;">
                            Key Findings</td>
		</tr>
		<tr>
			<td colspan="6" class="DetailValue" style="padding:5px;">
                        <span id="lblKeyFindings">This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk</span>
                        </td>
		</tr>
		<tr>
			<td colspan="6" class="DetailTitle" style="text-align:center;">
                            Potential use in non-academic contexts</td>
		</tr>
		<tr>
			<td colspan="6" class="DetailValue" style="padding:5px;">
                        <span id="lblNonAcademicUses">This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk</span>
                        </td>
		</tr>
		<tr>
			<td colspan="6" class="DetailTitle" style="text-align:center;">
                            Impacts</td>
		</tr>
		<tr>
			<td colspan="6" class="DetailValue" style="padding:5px;">
                            
                                    <table width="100%" cellspacing="0" cellpadding="0" class="bordered" summary="Impacts"> 
                                
                                  <tr style="margin-top: 2px; border-top: double 3px;"></tr>
                                  
                                  <tr>
                                    <td class="DetailName" style="font-weight: bold; ">Description</td>
                                    <td style="width:90%;FONT-WEIGHT: normal; " > This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk</td>
                                  </tr>
                                  <tr>
                                    <td class="DetailName" style="font-weight: bold;">Summary</td>
                                    <td style="width:90%;FONT-WEIGHT: normal;" > </td>
                                  </tr>
                                  <tr>
                                    <td class="DetailName" style="font-weight: bold;">Date Materialised</td>
                                    <td style="width:90%;FONT-WEIGHT: normal;" > </td>
                                  </tr>
                                  <tr style="margin-top: 2px; border-top: double 4px;"></tr>
                                
                                    </table>
                                   
                                
                           
                           
						</td>
		</tr>
		<tr>
			<td colspan="6" class="DetailTitle" style="text-align:center;">
                            Sectors submitted by the Researcher</td>
		</tr>
		<tr>
			<td colspan="6" class="DetailValue" style="padding:5px;">
                        <span id="lblResearchSectors">This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk</span>
                        </td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%;">Project URL:</td>
			<td colspan="5" class="DetailValueAlt">
							&nbsp;</td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%;">Further Information:</td>
			<td colspan="5" class="DetailValueAlt">
							&nbsp;</td>
		</tr>
		<tr>
			<td class="DetailName" style="width:20%;">Organisation Website:</td>
			<td colspan="5" class="DetailValue">
							<a  href='http://www.ed.ac.uk                                                                                 '>http://www.ed.ac.uk                                                                                 </a></td>
		</tr>
	</table>
	
				
   		        <div class="rightfloat"></div>
                <div class="clearfloat"></div>
    	
			
</div>
				
			
		</form>
	</body>
</html>
